Company intelligence / Profile preview

Thompson Financial

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Thomson Financial was a premier global provider of financial data, research, and technology services, serving as a critical information source for the life sciences and pharmaceutical industries. The company was widely recognized for its 'Thomson Pharma' platform, which offered comprehensive intelligence on drug development pipelines, clinical trial results, and patent landscapes. In 2008, Thomson Financial merged with Reuters Group to form Thomson Reuters, and its specialized life sciences division was later divested to become part of Clarivate. Today, the legacy of its healthcare data services continues to support biotech analysts and pharmaceutical strategic planning through successor platforms.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Thompson Financial.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Thompson Financial.

Explore the full profile